Understand the source comparison
Thymalin vs Cartalax vs Combination: Comparative Analysis
Primary Mechanism Thymulin hormone restoration → T-cell maturation in thymus AED tripeptide → eNOS upregulation in vascular smooth muscle Sequential immune + vascular pathway activation Complementary pathways justify stacking; neither pathway inhibits the othe
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Primary Mechanism
- Thymulin hormone restoration → T-cell maturation in thymus
- AED tripeptide → eNOS upregulation in vascular smooth muscle
- Sequential immune + vascular pathway activation
- Complementary pathways justify stacking; neither pathway inhibits the other
- Typical Dosing
- 10mg SC daily × 10 days
- Thymalin 10mg × 10 days, 48hr gap, then Cartalax 10mg × 10 days
- Sequential dosing prevents receptor saturation; overlapping administration offers no advantage
- Measurable Endpoints
- CD4+/CD8+ T-cell count increase, thymic index improvement
- Endothelial function (FMD), capillary density, NO metabolites
- Combined immune + vascular markers improve 25–40% more than solo protocols
- Clinical data from St. Petersburg Institute supports synergistic effect
- Reconstituted Stability
- 14 days at 2–8°C (oxidation-sensitive polypeptide)
- 28 days at 2–8°C (stable synthetic tripeptide)
- Reconstitute thymalin in smaller batches to match 14-day window
- Stability mismatch requires staggered reconstitution; don't mix in same vial
- Adverse Event Rate
- GI upset 8–12%, injection site reaction 5–7%
- Transient hypotension 3–5%, headache 2–4%
- Cumulative AE rate ~15% (additive, not synergistic)
- Side effects don't amplify when stacked; monitor BP if using cartalax
- Cost per 10-Day Cycle
- Approx. $180–240 (research-grade thymalin)
- Approx. $90–130 (synthetic cartalax)
- $270–370 for full 20-day sequential protocol
- Stacking doubles cost but produces measurably greater effect than solo use